| NDC Code | 51167-135-01 |
|---|
| Package Description | 4 BLISTER PACK in 1 CARTON (51167-135-01) / 21 TABLET, FILM COATED in 1 BLISTER PACK |
|---|
| Product NDC | 51167-135 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Alyftrek |
|---|
| Non-Proprietary Name | Vanzacaftor, Tezacaftor, And Deutivacaftor |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20241220 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA218730 |
|---|
| Manufacturer | Vertex Pharmaceuticals Incorporated |
|---|
| Substance Name | DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR |
|---|
| Strength | 50; 20; 4 |
|---|
| Strength Unit | mg/1; mg/1; mg/1 |
|---|
| Pharmacy Classes | Breast Cancer Resistance Protein Inhibitors [MoA], Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2C9 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|